Samenvatting
Ototoxicity and other neurologic toxicities are potential consequences of exposure to common therapeutic agents used during treatment of childhood cancer, including platinum and vinca alkaloid chemotherapy, cranial radiation, surgery involving structures critical to cochlear and neurologic function, and supportive care medications such as aminoglycoside antibiotics and loop diuretics. This article provides an overview of ototoxicity and other neurologic toxicities related to childhood cancer treatment, discusses the challenges that these toxicities may pose for survivors, and presents an overview of current recommendations for surveillance and clinical management of these potentially life-altering toxicities in survivors of childhood cancers.
Originele taal-2 | Engels |
---|---|
Pagina's (van-tot) | 1219-1235 |
Aantal pagina's | 17 |
Tijdschrift | Pediatric Clinics of North America |
Volume | 67 |
Nummer van het tijdschrift | 6 |
DOI's | |
Status | Gepubliceerd - dec. 2020 |